GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Chapman Investment Management LLC

Chapman Investment Management LLC boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 88,673 shares of the company’s stock after acquiring an additional 614 shares during the period. GE HealthCare Technologies comprises 5.2% of Chapman Investment Management LLC’s portfolio, making the stock its 8th largest holding. Chapman Investment Management LLC’s holdings in GE HealthCare Technologies were worth $6,856,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. First Command Advisory Services Inc. grew its holdings in shares of GE HealthCare Technologies by 36,900.0% during the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock worth $25,000 after buying an additional 369 shares in the last quarter. Legacy Financial Group LLC purchased a new stake in shares of GE HealthCare Technologies during the third quarter worth about $26,000. OFI Invest Asset Management purchased a new stake in shares of GE HealthCare Technologies during the third quarter worth about $26,000. ORG Partners LLC grew its holdings in shares of GE HealthCare Technologies by 174.2% during the third quarter. ORG Partners LLC now owns 425 shares of the company’s stock worth $29,000 after buying an additional 270 shares in the last quarter. Finally, Fortitude Family Office LLC purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $29,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.3 %

GEHC stock traded up $0.29 during mid-day trading on Friday, reaching $86.24. 1,790,728 shares of the stock traded hands, compared to its average volume of 2,231,738. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The stock’s fifty day moving average is $88.92 and its 200-day moving average is $78.45. The company has a market cap of $39.35 billion, a P/E ratio of 28.56, a P/E/G ratio of 2.99 and a beta of 0.94. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The firm had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. During the same quarter last year, the firm earned $1.31 earnings per share. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. As a group, sell-side analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.97%.

Analyst Ratings Changes

GEHC has been the subject of a number of recent research reports. Argus lifted their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Evercore ISI boosted their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. HSBC initiated coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price for the company. Citigroup boosted their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Finally, Mizuho boosted their target price on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.